app.png
Solutions

The strategic process of the DASEA Bio-Manufacturing platform “Intelligentized -- Digitalized -- AI"

凭借创新平台,中科睿极实现了细胞与外泌体全自动化与规模化制备,推动着再生医学领域的创新边界。

Advantages and Limitations of Exosomes in Regenerative Medicine Therapy

外泌体大规模制备应用方案-02.png

DASEA Solution For Exosome Large-scale Production

外泌体大规模制备应用方案-英文-03.jpg

Bio-manufacturing of Stem Cells Exosome (DASEA 3D vs 2D)

外泌体大规模制备应用方案-08(1).jpg

Pre-clinical Study

外泌体大规模制备应用方案-英文-04.jpg

Clinical Trials

Chronic cough after COVID-19

COVID-19 pneumonia

Primary sjogren's syndrome

Clinical trial on skin rejuvenation

外泌体大规模制备应用方案-英文-05.png 外泌体大规模制备应用方案-英文-06.png 外泌体大规模制备应用方案-英文-07.png 外泌体大规模制备应用方案-英文-08.png

Progress of Pre-clinical and Clinical Trial on Exosome

The statistical data as of Nov 4, 2024

Indications

Mechanism study

Production process

Quality inspection

Pre-clinical animal study

IIT

COVID-19 pneumonia

Long COVID-19 chronic cough

COVID-19 pneumonia

Dry eye disease

Androgenetic alopecia

Psoriasis

Scleroderma

COPD

Acute lung injur

Photoaging of the skin

Bone defects

中科睿极诚邀您一同探索
干细胞与外泌体的无限可能

中科睿极 公众号
x-index2.png
DASEA Lab 公众号
x-index3.jpg

电话icon(1).svg 0755 2641 2015

email.svg Enquiry@regengeek.com

dz.svg 总部:嘉兴市海宁市硖石街道水月亭东路500号鹃湖科技创新园6幢301室

dz.svg 商务中心:深圳市南山区工业五路5号万维大厦503

友情链接

x-slide1.png
x-slide2.svg 点我获取最新
细胞产业制备方案